110 related articles for article (PubMed ID: 19685398)
1. [Therapy monitoring in patients with multiple sclerosis based on transcriptomic analysis].
Zettl UK; Goertsches RH
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S64-8. PubMed ID: 19685398
[TBL] [Abstract][Full Text] [Related]
2. MS therapy research applying genome-wide RNA profiling of peripheral blood.
Goertsches R; Zettl UK
Int MS J; 2007 Sep; 14(3):98-107. PubMed ID: 18028834
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis.
Achiron A; Gurevich M
Autoimmun Rev; 2006 Oct; 5(8):517-22. PubMed ID: 17027885
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis therapy monitoring based on gene expression.
Goertsches R; Serrano-Fernández P; Möller S; Koczan D; Zettl UK
Curr Pharm Des; 2006; 12(29):3761-79. PubMed ID: 17073675
[TBL] [Abstract][Full Text] [Related]
5. Genomics in multiple sclerosis--current state and future directions.
Comabella M; Martin R
J Neuroimmunol; 2007 Jul; 187(1-2):1-8. PubMed ID: 17400297
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.
Lindberg RL; Kappos L
Expert Rev Mol Diagn; 2006 Nov; 6(6):843-55. PubMed ID: 17140371
[TBL] [Abstract][Full Text] [Related]
7. Translation towards personalized medicine in Multiple Sclerosis.
Miller A; Avidan N; Tzunz-Henig N; Glass-Marmor L; Lejbkowicz I; Pinter RY; Paperna T
J Neurol Sci; 2008 Nov; 274(1-2):68-75. PubMed ID: 18789804
[TBL] [Abstract][Full Text] [Related]
8. Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity.
Hesse D; Sellebjerg F; Sorensen PS
Neurology; 2009 Aug; 73(5):372-7. PubMed ID: 19652141
[TBL] [Abstract][Full Text] [Related]
9. Clustering samples characterized by time course gene expression profiles using the mixture of state space models.
Hirose O; Yoshida R; Yamaguchi R; Imoto S; Higuchi T; Miyano S
Genome Inform; 2007; 18():258-66. PubMed ID: 18546493
[TBL] [Abstract][Full Text] [Related]
10. Exploring cDNA phage display for autoantibody profiling in the serum of multiple sclerosis patients: optimization of the selection procedure.
Govarts C; Somers K; Hupperts R; Stinissen P; Somers V
Ann N Y Acad Sci; 2007 Aug; 1109():372-84. PubMed ID: 17785326
[TBL] [Abstract][Full Text] [Related]
11. Endogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis.
Perron H; Bernard C; Bertrand JB; Lang AB; Popa I; Sanhadji K; Portoukalian J
J Neurol Sci; 2009 Nov; 286(1-2):65-72. PubMed ID: 19447411
[TBL] [Abstract][Full Text] [Related]
12. Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis.
Morris AH; Hughes KR; Oakes RS; Cai MM; Miller SD; Irani DN; Shea LD
Nat Commun; 2020 Aug; 11(1):3871. PubMed ID: 32747712
[TBL] [Abstract][Full Text] [Related]
13. United Europeans for development of pharmacogenomics in multiple sclerosis network.
Vandenbroeck K; Comabella M; Tolosa E; Goertsches R; Brassat D; Hintzen R; Infante-Duarte C; Favorov A; Escorza S; Palacios R; Oksenberg JR; Villoslada P
Pharmacogenomics; 2009 May; 10(5):885-94. PubMed ID: 19450134
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis.
Petersen T; Møller-Larsen A; Thiel S; Brudek T; Hansen TK; Christensen T
J Neuroimmunol; 2009 Oct; 215(1-2):108-16. PubMed ID: 19766328
[TBL] [Abstract][Full Text] [Related]
15. Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.
Nickles D; Chen HP; Li MM; Khankhanian P; Madireddy L; Caillier SJ; Santaniello A; Cree BA; Pelletier D; Hauser SL; Oksenberg JR; Baranzini SE
Hum Mol Genet; 2013 Oct; 22(20):4194-205. PubMed ID: 23748426
[TBL] [Abstract][Full Text] [Related]
16. Twin studies and the heritability of MS: a conclusion.
Hawkes CH; Macgregor AJ
Mult Scler; 2009 Jun; 15(6):661-7. PubMed ID: 19482860
[TBL] [Abstract][Full Text] [Related]
17. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
Debouverie M
J Neurol Sci; 2009 Nov; 286(1-2):14-7. PubMed ID: 19691994
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles.
Cho WS; Kim S; Han BS; Son WC; Jeong J
Toxicol Lett; 2009 Dec; 191(1):96-102. PubMed ID: 19695318
[TBL] [Abstract][Full Text] [Related]
19. Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?
Drulovic J; Savic E; Pekmezovic T; Mesaros S; Stojsavljevic N; Dujmovic-Basuroski I; Kostic J; Vasic V; Mostarica Stojkovic M; Popadic D
J Neuroimmunol; 2009 Oct; 215(1-2):90-5. PubMed ID: 19695714
[TBL] [Abstract][Full Text] [Related]
20. Microchips for cell-based assays.
Dufva M
Methods Mol Biol; 2009; 509():135-44. PubMed ID: 19212719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
